Stay updated on Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.
    Difference
    2%
    Check dated 2025-10-06T05:53:06.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:10:24.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Updated revision to v3.0.2 and removed the 'Back to Top' element. Overall, core content remains unchanged.
    Difference
    0.1%
    Check dated 2025-09-14T19:07:46.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T15:18:30.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, particularly in Poland and the United States, as well as new drug information for Lebrikizumab. Additionally, several previous location entries have been removed.
    Difference
    8%
    Check dated 2025-08-31T11:52:03.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:23:54.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.